Harmony Biosciences Holdings (HRMY) Return on Sales (2020 - 2026)

Harmony Biosciences Holdings' Return on Sales history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at Harmony Biosciences Holdings, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2022 to a low of 0.0% in Q4 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 1 bps in 2022 and fell as far as 1 bps in 2022.
• Harmony Biosciences Holdings' Return on Sales stood at 0.0% in 2022, then soared by 154 bps to 0.0% in 2023, then surged by 148 bps to 0.0% in 2024, then sank by 61 bps to 0.0% in 2025, then declined by 1 bps to 0.0% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison